Literature DB >> 22820712

Preexposure prophylaxis for HIV infection.

Robert Steinbrook1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820712     DOI: 10.1001/jama.2012.9885

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  New generation humanized mice for virus research: comparative aspects and future prospects.

Authors:  Ramesh Akkina
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

Review 2.  Infection in 2012: mixed results of pre-exposure prophylaxis for HIV prevention.

Authors:  Ronald H Gray; Maria J Wawer
Journal:  Nat Rev Urol       Date:  2013-01-15       Impact factor: 14.432

Review 3.  Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

4.  Ethics and pre-exposure prophylaxis for HIV infection.

Authors:  Jeremy Sugarman; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

5.  Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial.

Authors:  Freddie M Kibengo; Eugene Ruzagira; David Katende; Agnes N Bwanika; Ubaldo Bahemuka; Jessica E Haberer; David R Bangsberg; Burc Barin; James F Rooney; David Mark; Paramesh Chetty; Patricia Fast; Anatoli Kamali; Frances H Priddy
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.